ABSTRACT
 

The field of oncology is rapidly changing. Not only is treatment becoming more precise, but the speed of innovation is compounding each year. As more targeted therapies come to market, more patients have the hope of living a longer life.

​

For oncologists, the amount of critical information that must be taken into account at the point of care is steadily increasing, making it nearly impossible for general providers—and even specialists—to keep up. This can lead to over- or under-testing and inconsistent treatment decisions, even for providers within the same practice.

​

​

​

A 2019 ASCO abstract revealed that oncologists incorrectly matched the molecular alteration to the targeted therapy in up to 69% [of cases].

​

​

​

Some cancer centers have implemented clinical data systems, but those do not connect the dots between diagnosis, the most appropriate tests and treatments, what a patient could be pre-approved for, or what payers are most likely to cover. This lack of alignment with payer policies exacerbates an already complex system by slowing the decision-making process.

​

Combined, these challenges make it difficult for practices to standardize quality care regardless of their size or resources. Finding
a solution that empowers physicians in their daily practice is imperative to speed progress in the effective use of precision medicine. 

​

In this paper, we will explore seven key reasons it is now critical to standardize precision medicine in oncology care and the ways that leading cancer centers and community oncologists are successfully implementing decision-support solutions to drive change. 

 

This in-depth and highly visual whitepaper covers:

​

• Why testing and treatment decisions may be inconsistent across your practice

• How to prevent over- and under- testing and align on appropriate treatments, including clinical trials

• What an advanced technology solution that standardizes care
  for an entire organization could look like

 

​